Stavros Petrou
Statistics and Probability · 2011–2022
A researcher in the Science corpus: 8 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 29 citations into it
Whom Stavros Petrou trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Stavros Petrou's perspective
Ordered by how strongly the researchers Stavros Petrou trusts endorse each paper. Same corpus, a different order for every researcher.
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (British medical journal)
- CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (Obstetrics and Gynecology)
- PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (British medical journal)
- The estimation of a preference-based measure of health from the SF-36. (Journal of Health Economics)
- Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study (PLoS Medicine)
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. (The Lancet)
- Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses (British medical journal)
- Guidance for Developers of Health Research Reporting Guidelines (PLoS Medicine)
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (British medical journal)
- Subgroup analysis and other (mis)uses of baseline data in clinical trials.
Their papers
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. (2022) — 647 citations
- Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations (2022) — 1,522 citations
- Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. (2021) — 1,068 citations
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). (2018) — 1,156 citations
- A Randomized Trial of Epinephrine in Out‐of‐Hospital Cardiac Arrest (2018) — 629 citations
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. (2013) — 1,835 citations
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013) — 2,158 citations
- Perinatal and maternal outcomes by planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national prospective cohort study (2011) — 824 citations